Valuation: BYND Cannasoft Enterprises Inc.

Market Cap 718K 507K 444K 410K 378K 48.36M 730K 4.9M 1.92M 23.87M 1.9M 1.86M 81.98M P/E 2024 *
-
P/E 2025 0.02x
Enterprise Value -14.51M -10.24M -8.99M -8.28M -7.65M -978M -14.76M -98.98M -38.76M -483M -38.5M -37.66M -1.66B EV / Sales 2024
2.92x
EV / Sales 2025 -17.5x
Free-Float
50.94%
Yield 2024 *
-
Yield 2025 -
May. 28 Femto Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
Apr. 30 Tranche Update on Femto Technologies Inc. (OTCPK:FMTO.F)'s Equity Buyback Plan announced on May 15, 2025. CI
Apr. 30 Tranche Update on Femto Technologies Inc. (OTCPK:FMTO.F)'s Equity Buyback Plan announced on May 15, 2025. CI
Apr. 30 Femto Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
Mar. 29 Femto Technologies Inc. (OTCPK:FMTO.F) completed the acquisition of 40% stake in Gilad R.G. Planning and Implementation of Technologies & Software 2025 Ltd. CI
Mar. 26 Femto Technologies Inc. (OTCPK:FMTO.F) entered into a share purchase agreement to acquire 40% stake in Gilad R.G. Planning and Implementation of Technologies & Software 2025 Ltd for $2 million. CI
Feb. 17 Femto Technologies Inc. Announces U.S. Launch of Sensera, A Next-Generation Femtech Device CI
Nov. 25 Femto Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
Nov. 13 Femto Technologies Inc.'s Equity Buyback announced on May 15, 2025, has expired with 19,747 shares, for $0.13 million. CI
25-09-29 Femto Technologies Inc. Appoints Mor Bzizinsky to its Board of Directors CI
25-09-04 Femto Technologies Inc. Appoints Stefania Szabo as Chairperson of the Board, Effective September 4, 2025 CI
25-08-29 Femto Technologies Inc. Announces Positive Results from Pre-Launch User Experience Study of Sensera Device CI
25-08-27 Femto Technologies Inc. Announces Board and Committee Changes CI
Manager TitleAgeSince
Chief Executive Officer 47 -
Chief Executive Officer 68 -
Director of Finance/CFO 52 2020-07-31
Director TitleAgeSince
Director/Board Member 63 2021-03-28
Director/Board Member 47 2021-03-28
Director/Board Member 52 2020-07-31
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 507K
+0.19%-1.38%-23.21%+16.05% 2,861B
-1.74%-1.94%-11.02%+677.85% 304B
-8.80%+3.47%+298.47%+959.10% 130B
-0.46%+2.96%+19.06%+63.88% 106B
-4.26%-1.08%+87.32%+153.86% 91.67B
+0.48%+1.91%-21.32%-0.05% 85.3B
+1.86%+7.59%-25.61%+91.49% 68.07B
-1.18%-4.62%+3.34%+68.96% 45.15B
-1.91%-0.11%-47.30%+32.96% 39.63B
Average -1.58%+0.79%+31.08%+229.34% 414.46B
Weighted average by Cap. -0.41%-0.93%-7.05%+109.35%

Financials

2024 2025
Net sales 999K 705K 618K 570K 527K 67.29M 1.02M 6.81M 2.67M 33.21M 2.65M 2.59M 114M 847K 598K 524K 483K 446K 57.03M 861K 5.77M 2.26M 28.15M 2.25M 2.2M 96.69M
Net income -47.59M -33.59M -29.47M -27.15M -25.09M -3.21B -48.4M -325M -127M -1.58B -126M -123M -5.44B 12.92M 9.12M 8M 7.37M 6.81M 871M 13.14M 88.13M 34.51M 430M 34.28M 33.53M 1.48B
Net Debt -4.58M -3.23M -2.83M -2.61M -2.41M -308M -4.65M -31.21M -12.22M -152M -12.14M -11.88M -523M -15.23M -10.75M -9.43M -8.69M -8.03M -1.03B -15.49M -104M -40.67M -506M -40.4M -39.53M -1.74B
Logo BYND Cannasoft Enterprises Inc.
Femto Technologies Inc., formerly BYND Cannasoft Enterprises Inc., is an integrated software company. It pioneers in women's care technology, focused on advancing women's wellness and lifestyle, leveraging its Smart Release Technology and core ability to innovate data-driven products to focus on the development of smart products in the sectors of intimacy, sports, hair, and cosmetics. It owns and markets Benefit CRM, a customer relationship management (CRM) software product enabling small and medium-sized businesses to optimize their day-to-day business activities such as sales management, personnel management, marketing, call center activities, and asset management. It owns the intellectual property for the EZ-G device. This therapeutic device uses proprietary software to regulate the flow of low concentrations of cannabidiol oil, hemp seed oil, and other natural oils into the soft tissues of the female reproductive system to potentially treat a variety of women's health issues.
Employees
-